Zomig Nasal Spray is indicated for the acute treatment of migraine with or without aura.
AstraZeneca announced that it has entered an agreement with Grünenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig...
The FDA has approved Noctiva (desmopressin acetate) nasal spray from Serenity Pharmaceuticals for adults who awaken at least two times...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Commission (EC) has approved Spravato (esketamine) nasal spray,...
The EC has authorised SPRAVATO (esketamine) nasal spray in combination with a selective serotonin reuptake inhibitor or serotonin and norepinephrine reuptake inhibitor.